Divergent Pathways in COS-7 Cells Mediate Defective Internalization and Intracellular Routing of Truncated G-CSFR Forms in SCN/AML by Hunter, Melissa G. et al.
Divergent Pathways in COS-7 Cells Mediate Defective
Internalization and Intracellular Routing of Truncated G-
CSFR Forms in SCN/AML
Melissa G. Hunter
1,2, Morgan McLemore
3, Daniel C. Link
4, Megan Loveland
5, Alexander Copelan
6,
Belinda R. Avalos
2,5*
1Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University, Columbus, Ohio, United States of America, 2Davis Heart and Lung Research Institute,
The Ohio State University, Columbus, Ohio, United States of America, 3Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, United States of
America, 4Division of Bone Marrow Transplantation and Stem Cell Biology, Washington University, St. Louis, Missouri, United States of America, 5Division of Hematology/
Oncology, The Ohio State University, Columbus, Ohio, United States of America, 6Johns Hopkins University, Baltimore, Maryland, United States of America
Abstract
Background: Expression of truncated G-CSFR forms in patients with SCN/AML induces hyperproliferation and prolonged cell
survival. Previously, we showed that ligand internalization is delayed and degradation of truncated G-CSFR forms is
defective in patients with SCN/AML.
Methodology/Principal Findings: In this study, we investigated the potential roles of dileucine and tyrosine-based motifs
within the cytoplasmic domain of the G-CSFR in modulating ligand/receptor internalization. Using standard binding assays
with radiolabeled ligand and COS-7 cells, substitutions in the dileucine motif or deletion of tyrosine residues in the G-CSFR
did not alter internalization. Attachment of the transferrin receptor YTRF internalization motif to a truncated G-CSFR form
from a patient with SCN/AML corrected defective internalization, but not receptor degradation suggesting that receptor
internalization and degradation occur independently via distinct domains and/or processes.
Conclusions: Our data suggest that distinct domains within the G-CSFR mediate separate processes for receptor
internalization and degradation. Our findings using standard binding assays differ from recently published data utilizing
flow cytometry.
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Introduction
Granulocyte colony-stimulating factor (G-CSF) critically regu-
lates neutrophil numbers by binding to the G-CSF receptor (G-
CSFR) to generate signals that maintain a homeostatic balance
between myeloid cell survival, proliferation, and differentiation [1–
4]. Despite continued progress in our understanding of the
signaling pathways that are activated by the G-CSFR to transduce
mitogenic signals, little is currently known about the mechanisms
by which the G-CSFR downregulates proliferative signaling.
For those growth factor receptors that have been studied,
ligand-induced receptor internalization has been shown to
critically control cellular responsiveness [5–9]. Following ligand
binding, most receptors are recruited to clathrin-coated pits where
they are endocytosed then internalized and either recycled back to
the cell surface or degraded within intracellular compartments.
Sorting signals within the cytosolic tails of the receptors have been
identified that direct trafficking of the receptors [10]. Tyrosine-
containing and dileucine-containing regions are two characteristic
motifs responsible for endosomal-lysosomal targeting of receptor
proteins. Receptor internalization and degradation serve to
attenuate receptor signaling by rapidly down-modulating or
decreasing the number of receptors on the cell surface to protect
cells from over-stimulation. Receptor trafficking also controls the
specific signaling pathways triggered by activated receptors and
the intensity of signaling [9,11,12].
Abnormalities in both receptor oligomerization and trafficking
have been shown to alter normal receptor function and ligand
sensitivity and to contribute to human diseases [13–16].Our
laboratory previously reported that ligand internalization and
receptor degradation are impaired leading to sustained cellular
activation and enhanced cell survival and proliferation in patients
with severe congenital neutropenia (SCN) transforming to (AML)
in which a truncated G-CSFR is expressed along with the wild
type form [17]. Our data were subsequently confirmed by others
in both in vitro and in vivo studies [18,19].
The precise defects responsible for abnormal degradation and
modulation of surface expression of the G-CSFR in SCN/AML
remain unknown. In this study, we have examined the roles of
known internalization motifs within the cytoplasmic domain of the
PLoS ONE | www.plosone.org 1 June 2008 | Volume 3 | Issue 6 | e2452G-CSFR to determine whether they modulate G-CSFR internal-
ization and degradation. Our data suggest that the G-CSFR
utilizes distinct and separate processes for receptor internalization
and degradation as a mechanism for regulating receptor surface
expression and recruitment of specific signaling pathways.
Methods
Reagents
Cell culture reagents, restriction enzymes, and oligonucleotides
were purchased from Invitrogen Inc. (Carlsbad, CA). G-CSF was
a generous gift from Amgen Inc (Thousand Oaks, CA). [I
125]G -
CSF (.800ci/mmol) and Pro-mix [
35S] in vivo cell labeling mix
(.1000ci/mmol) were obtained from Amersham (Arlington
Heights, IL). All other reagents were purchased from Sigma
Chemical Co (St. Louis, MO) unless otherwise indicated.
DNA constructs
The construction of pCDNA3.1-WT, the wild-type human
Class I G-CSFR cDNA (generously provided by Dr. A. Larsen,
Seattle, WA) and pCDNA3.1-D716 have been previously reported
[17]. Tyrosine to phenylalanine (YRF) mutations at amino acid
positions 729 and 764 of the WT G-CSFR were introduced by site
directed mutagenesis and the corresponding G-CSFR forms were
designated Y729F and Y764F, respectively. To generate Y729F
and Y764F, an A to T point mutation at nt. 2465 or 2525 was
introduced, respectively, in the WT-G-CSFR cDNA by overlap
extension PCR [17]. The oligonucleotides used to generate these
mutants were: forward primer Y29F F1 (59-GGCACC-
CAGCCTGCCCAAAAAGTACTTGATC-39), forward primer
Y764F F2 (59-GGCCAGGGCACTTTCTCCGCTGTGA-
CTCCACTC-39), reverse primer Y729F R1 (59-GCCCAG-
CAGCGATCAAGTACTTTTTGGGCAGCT -39), and reverse
primer Y764F R2 (59-GGAACCAGAAATTCTCAAAGC-
TTTTGGGG CTGG-39); the underlined nucleotides indicate
the positions of the point mutations. To generate Y744F, primer
F3 containing a 59 restriction site for Bam HI and corresponding to
nts. 2252-2268 of the WT-G-CSFR cDNA was used in
conjunction with the Y729F R1, to amplify WT-G-CSFR cDNA.
In a separate PCR reaction, WT-G-CSFR cDNA was amplified
with Y729F F1 primer and primer R3 that was designed to
contain a Xho I restriction site and corresponded to nts. 2581-2596
of the WT-G-CSFR cDNA. The products from the two initial
PCR reactions were combined and amplified by PCR using the
external primers F3 and R3. The PCR product was digested with
Xho I and Bam HI and then subcloned into the Xho I and Bam HI
sites of pBluescript SK
+. An internal 280bp fragment in the cloned
product was excised from pBluescript SK
+ by Cfr10I and BstE II
digestion, gel purified, and cloned into WT cDNA replacing WT
sequences. This plasmid was designated pCDNA3.1-Y729F.
To generate the Y764F mutant, primer pairs Y764F F2/R3 and
F3/Y764F R2 were used in initial PCR reactions and the resulting
PCR products further amplified with oligonucleotides F3 and R3.
The same cloning strategy was used to generate pCDNA3.1-
Y764F.
Point mutations at amino acid residues 753, 754, or both 753
and 754 of the WT G-CSFR were generated using the
Transformer Site-Directed Mutagenesis kit (BD Clontech, Palo
Alto, CA) and designated L753A, L754A, and L753/754A G-
CSFR. Briefly, ssDNA was generated from plasmid DNA
containing the WT G-CSFR cDNA by incubation at 100uC for
5 min. Mutagenic oligonucleotides specific for the G-CSFR, and
vector mutagenic oligonucleotide (59-PO4-CTCTGGGGATC-
GATATGACCGACC-39) which changes a SfuI restriction site
to ClaI restriction site (underlined) were annealed to the ssDNA
template then incubated with reaction buffer containing T4 DNA
polymerase and T4 DNA ligase for 90 min at 37uC. The following
59-phosphorylated oligonucleotides were used to generate L753A
(59-TGACTCCACTCAGCCGGCTTTGGCGGGCCTCAC -39),
L754A (59-TGTGACTCCACTCAGCCTCTAGCCGCGGGCC-
TC-39), and L753/754A (59-TGTGACTCCACTCAGCCTG-
CCGCGGCGGGCCTCAC-39). In addition to the Leu to Ala
substitutions (underlined), silent mutations were made to generate a
NaeI restriction site in L753A and a KspI restriction site in both the
L754A and L753/754A cDNA. The DNA was digested with SfuIa n d
transformed into BMH 71-18 mutS competent cells, which is a repair
defective strain of E. coli whichpreferentiallyselectsmutated DNAfor
replication. The DNA was isolated and restriction digested with SfuI
and transformed into DH5a E. coli a n ds e l e c t e df o ra m p i c i l l i n
resistance. The introduced mutations were confirmed by restriction
endonuclease digestion and sequencing.
The QuikChange Site-Directed Mutagenesis kit (Stratagene, La
Jolla, CA) was used to construct the D716-YTRF G-CSFR form in
which the YTRF internalization sequence from the transferrin
receptor was inserted 59 to the stop codon in D716 cDNA. Briefly,
cDNA corresponding to D716 G-CSFR form subcloned into
pBluescript SK+ was denatured and incubated with mutagenic
sense (59-GCAGTTTCCACCTATACCCGGTTCTAGCC-
CCAATCCC-39) and antisense (59-GGGATTGGGGCTA-
GAACCGGGTATAGGTGGA-AACTGC-39) oligonucleotides
containing the sequence encoding for amino acid residues YTRF
(underlined) and Pfu Turbo DNA polymerase. Nonmutated
parental DNA which is methylated was digested using methylation
sensitive restriction enzyme, DpnI. Supercompetent cells were
transformed with the mutated nicked dsDNA for repair and
amplification. Introduction of the YTRF sequence introduced an
additional NciI restriction site allowing confirmation of the
addition of YTRF sequence by restriction digestion. cDNA was
subcloned into pCDNA3.1 and sequenced to confirmed the
addition of YTRF to the D716 G-CSFR.
Transfections and cell culture
COS-7 cells were grown in DMEM supplemented with 10%
FBS and were transiently transfected by calcium phosphate
precipitation with plasmid DNA, as previously described [17].
An equivalent amount of plasmid DNA was used for single
transfections in COS-7 cells.
Internalization studies
Ligand internalization was performed as previously reported
[17]. Briefly, cells were incubated with 500pM [I
125] G-CSF for
2 h at 4uC. Internalization of radiolabeled ligand was examined by
temperature shifting to 37uC for varying times from 30 to 120
mins. Following incubation at 37uC, the cells were incubated for
an additional 2 h at 4uC. To remove unbound ligand, cells were
washed in cold PBS containing 1mM MgCl2, 0.1mM CaCl2, and
0.2% BSA. Surface-bound [I
125] G-CSF was removed by
incubation with 0.5M NaCl (pH1.0) for 3 mins followed by
washing in cold PBS solution. The acid strip solution and wash
were both collected to determine bound ligand. Internalized ligand
was quantified by lysis of the cells with 1M NaOH for 1min. The
data were expressed as percent internalization over time [20].
Analysis of specific binding was also performed in the presence of
excess cold ligand as previously described [17,21,22].
Receptor degradation
Transfected COS-7 cells grown to confluency in T75 flasks were
incubated with short-term labeling media (RPMI 1640 media
G-CSFR Trafficking
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for 15 mins at 37uC. Cells were metabolically labeled with [
35S]
Cysteine/Methionine Pro-mix at 0.15mCi/ml in short-term
labeling media for 1 h at 37uC as previously described
[10,20,23]. The cells were washed with incubation media (RPMI
1640 containing 10% FBS, 1nM G-CSF, and unlabeled
methionine and cysteine) and incubated for varying times, then
washed once in PBS, scraped and pelleted. The cell pellets were
lysed in buffer containing 1% NP-40 (Boehringer Mannheim
Biochemical, Indianapolis, IN), 1mM EDTA (pH 8.0), 20mM Tris
(pH 8.0), 150mM NaCl, 0.15U/ml aprotinin, 10 mg/ml leupeptin,
10 mg/ml pepstatin A and 1mM sodium vanadate, then cleared of
insoluble material. Lysates were pre-cleared with protein A
agarose (Invitrogen), immunoprecipitated with 8 mg anti-G-CSFR
antibody recognizing the N-terminal portion of the G-CSFR (BD
PharMingen, San Diego, CA), and analyzed under reducing
conditions by SDS-PAGE. The gels were treated with Entensify
(DuPont-NEN, Wilmington, DE) according to the manufacturer’s
instructions and dried. The labeled proteins were visualized by
autoradiography.
Results
Role of dileucine and tyrosine-based motifs in the G-CSFR
in ligand-receptor internalization
Since efficient internalization of many growth factor receptors
has been shown to be mediated by dileucine or tyrosine-based
motifs in the cytoplasmic domains of these receptors [24–26], we
investigated whether dileucine and tyrosine-based motifs present
in the WT G-CSFR but absent in the D716 G-CSFR form might
mediate internalization of the G-CSFR complex. Mutations in the
G-CSFR corresponding to these motifs were therefore introduced.
In previous studies using the Ba/F3 pro-B cell line, and COS-7
cells expressing the WT and truncated G-CSFR forms, we
demonstrated that ligand internalization and down-modulation of
G-CSFR expression were impaired in cell lines expressing the
D716 G-CSFR, which is the most common mutant G-CSFR form
identified in patients with AML and antecedent SCN [17]. The
D716 G-CSFR form arises due to a C to T substitution resulting in
the generation of a premature stop codon (Figure 1).
To confirm whether our observations of defective internaliza-
tion and prolonged receptor surface expression in transfected Ba/
F3 and COS-7 cells held true in myeloid cells, studies with primary
myeloid cells from mice expressing the truncated form of the G-
CSFR were done. Similar to our in vitro studies, we observed that
G-CSF internalization and down-modulation of the G-CSFR in
myeloid cells from the ‘‘knock-in’’ mice are also impaired (data not
shown). Since these observations were consistent with our previous
in vitro observations [17], additional studies were performed using
COS-7 cells.
The WT G-CSFR contains an STQPLL dileucine motif in its
cytoplasmic domain at aa. 749–754 which is identical to the
dileucine motif in the cytoplasmic domain of the homologous
gp130 molecule which mediates IL-6 internalization and down-
modulation of the IL-6R [20,23]. Both leucine residues in the
dileucine motif of gp130 have been shown to be essential for IL-6
internalization [27]. In temperature-shift and acid washing studies
with G-CSFR mutants containing either single or double leucine
to alanine substitutions at residues 753 and 754, no significant
differences in internalized ligand were observed between the WT
and LRA transfectants (Figure 2). Ligand internalization was
apparent within 30 minutes in cells expressing L753A, L754A,
L753/754A, or the WT G-CSFR, with nearly 40% of bound
ligand internalized by 30 minutes. Only small increases in
internalized ligand were observed at 1 h and 2 h, suggesting
ligand internalization is nearly complete by 30 minutes. In
contrast, ligand internalization was significantly delayed in the
truncated D716 G-CSFR (p,0.05 for 30-120 minute time points,
compared to WT). These results suggest that unlike the
homologous gp130 molecule other cytoplasmic motifs in the G-
CSFR mediate ligand/receptor internalization.
Tyrosine-based motifs in the G-CSFR do not mediate
ligand-receptor internalization
We next investigated the role of tyrosine residues in the
cytoplasmic tail of the G-CSFR in mediating receptor internali-
zation. Since Tyr
729 and Tyr
764 correspond to known tyrosine-
based motifs for other receptors [28] and are deleted in the D716
G-CSFR, G-CSFR mutants containing tyrosine to phenylalanine
mutations at these locations were generated and designated Y729F
and Y764F, respectively. As shown in Figure 3, significant levels of
internalized
125 I -G-CSF were detected in cells expressing the
Y729F and Y764F G-CSFR forms. There was no evidence for
defective ligand internalization with the Y729F or Y764F G-CSFR
forms compared to the WT G-CSFR over the 2 h time period
examined. Although the Y729F receptor mutant exhibited a trend
suggesting accelerated internalization compared to the WT
receptor form, this was found to be not statistically significant
(p=0.37). These results suggest that loss of either tyrosine residue
at position 729 or 764 does not alter ligand/receptor internaliza-
tion. We also examined the remaining two G-CSFR cytoplasmic
tyrosine residues at positions 704 and 744 by introducing tyrosine
to phenylalanine mutations and examining ligand internalization
in COS-7 cells transduced with these mutant G-CSFR forms, and
observed no appreciable alterations in ligand/receptor internali-
zation (data not shown).
Effect of a C-terminal YTRF internalization motif on
internalization and degradation of the D716 G-CSFR
Since our collective data indicated that other sequences in the
G-CSFR must regulate ligand/receptor internalization, and since
we previously showed that both internalization and degradation of
ligand/receptor complexes are impaired in cells expressing the
D716 G-CSFR, we were interested in determining whether
insertion of a known internalization motif into the D716 G-CSFR
could correct these defects. For these studies, the YTRF
internalization motif of the transferrin receptor [23] was inserted
in-frame and 59 to the stop codon of the truncated D716 G-CSFR
and ligand/receptor internalization and degradation were exam-
ined. As shown in Figure 4A, attachment of the YTRF motif
corrects the defect in ligand/receptor internalization in cells
expressing the D716-YTRF G-CSFR. Internalized
125I-labeled G-
CSF was observed within 30 minutes in cells expressing the WT
G-CSFR or the D716-YTRF G-CSFR to which the YTRF motif
had been attached. At each time point examined, cells expressing
the D716-YTRF receptor form had significantly higher levels of
internalized ligand compared to the D716 G-CSFR lacking the
fused internalization motif (p,0.01 at each time point).
We next examined whether correction of the internalization
defect in D716 cells by attachment of the YTRF motif also
restored receptor degradation back to normal. We have previously
shown that degradation of the WT G-CSFR occurs within 2 h
following ligand exposure [17], whereas degradation of the
truncated D716 G-CSFR is delayed even at 4 h. As shown in
Figure 4B, there was no evidence that attachment of the YTRF
motif corrected the defect in receptor degradation in cells
expressing the D716 G-CSFR. The half-life of the WT G-CSFR
G-CSFR Trafficking
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5.9 h61.02 for D716 and D716-YTRF, respectively (WT vs.
D716, p=0.013 and WT vs. D716-YTRF, p=0.13). No
significant difference in receptor half-life was observed between
D716 and D716-YTRF G-CSFR forms (p=0.24).
Discussion
SCN is characterized by neutropenia with frequent and often
severe bacterial infections [29]. The neutropenia of these patients
is generally responsive to pharmacological doses of G-CSF.
However, 21% of patients will ultimately develop AML [30].
Mutations in one allele of the gene for the G-CSFR have been
identified in 78% of these patients [30,31]. These mutations
introduce a premature stop codon that truncates the cytoplasmic
tail of the G-CSFR resulting in hypersensitivity to G-CSF,
resistance to apoptosis, and enhanced cell proliferation. Collec-
tively, these observations have led to the postulation that G-CSFR
mutations contribute to leukemogenesis in patients with SCN [32].
We and others have previously demonstrated sustained
intracellular signaling in response to G-CSF in cells expressing
truncated G-CSFR forms isolated from patients with SCN/AML
[18,19,33]. Our laboratory has also shown that internalization and
degradation of the truncated G-CSFR forms is impaired [17].
Y          Y           Y        Y
EX               TM         1            2                  ID                      3      
STQPL753L754
Dileucine Motif
Y          F           Y        Y
Y          Y           F        Y
Y          Y           Y        F
Y          
Y          
YTRF
WT
Y729F
Y744F
Y764F
∆716
∆716-YTRF
Figure 1. Schematic diagram of G-CSFR forms. The extracellular (EX), transmembrane (TM), and intracellular (ID) domains of the various G-CSFR
forms are shown with the conserved box 1, 2, and 3 regions indicated. The full-length wild-type (WT) G-CSFR contains four cytoplasmic tyrosine
residues at a.a. positions 704, 729, 744, and 764. The location of the dileucine motif in the WT G-CSFR at residues 749-754, which is deleted in D716,
where Leu to Ala substitutions were introduced to generate the L753A, L754A, and the L753/754A G-CSFR is shown. Tyr to Phe substituitions at either
Tyr
729, Tyr
744, or Tyr
764 were also introduced and the corresponding G-CSFR mutants designated Y729F, Y744F, and Y764F, respectively. The D716 G-
CSFR was isolated from a patient with SCN/AML and contains a premature stop codon resulting in a truncated G-CSFR. The D716 -YTRF mutant was
generated by attachment of the transferrin receptor YTRF internalization motif 59 to the stop codon of the D716 G-CSFR.
doi:10.1371/journal.pone.0002452.g001
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type A insulin resistance, and familial hypercholesterolemia in
which aberrant down-modulation of growth factor receptors has
been shown to play a role in the pathophysiology of these diseases
[13–16], disruption of receptor trafficking also appears to underlie
altered cell signaling in SCN/AML. In this study, we have further
investigated the mechanisms that modulate G-CSFR expression
and are responsible for G-CSFR internalization and degradation.
For other growth factor receptors, down-modulation of their
surface expression has been shown to be mediated by specific
amino acid motifs in the receptors themselves and/or involve the
recruitment and association of adaptor proteins with the receptors
which then target the receptors to intracellular compartments for
degradation, recycling, or both [28]. Dileucine motifs in a number
of cell surface proteins have been reported to mediate their
internalization and sorting in the trans-Golgi apparatus as well as
trafficking to the lysosome [24,26]. Leucine-based internalization
motifs have been identified in the mannose 6-phosphate/Insulin –
like growth factor receptor, insulin receptor, CD3c chain,
epidermal growth factor receptor, leukemia inhibitory factor
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[7,9,20,23,25,26,34,35]. In the gp130 subunit, substitution of the
leucine residues in the dileucine STQPLL motif with alanines was
shown to dramatically alter trafficking of the IL-6 receptor
complex with a near complete loss in the capacity to internalize
the receptor complex [20]. In addition, tyrosine containing motifs
have also been identified that mediate the internalization of several
growth factor receptors, including the receptors for transferrin, low
density lipoprotein, IL-2-receptor b chain, and receptors for the
insulin-like growth factor (IGF) and mannose 6-phosphate as well
as the B-cell receptor a chain,[28,36–40].
Since the identical STQPLL dileucine motif in gp130 that
mediatesIL-6Rinternalizationisalsopresentatresidues749–754in
the G-CSFR [17,20,23], we were interested in determining the role
of this motif in internalization of G-CSF/G-CSFR complexes.
Notably, this motif is deleted in the D716-G-CSFR in patients with
SCN/AML. Substitution of either leucine residue or both leucines
in this motif in the G-CSFR with alanines had no effect on ligand/
receptor internalization, suggesting that the G-CSFR utilizes other
mechanisms to regulate its own surface expression. Our results
contrast with an earlier report by Aarts et. al. demonstrating that
mutation of both leucine residues in the STQPLL motif inhibited
internalization of the G-CSFR. They reported that mutation of
both leucinesor the serineresidue inthe cytoplasmic dileucinemotif
of the G-CSFR resulted in approximately 50% reduction in
receptor endocytosis in 32D cells [41]. The reasons for the
discrepancies in our findings and theirs are not clear. It is possible
that the differences relate to differences in the cell models used.
Since a potential kinase that binds to the dileucine motif to mediate
G-CSFR internalization has been postulated [41], it is possible that
the unknown kinase is not expressed in COS-7 fibroblast cells.
Previous studies with the homologous gp130 molecule of the IL-6R
demonstrating a role for the STQPLL motif in receptor
internalization utilized a fibroblast model [20,23]. Hence unlike
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in regulation of G-CSFR surface expression in a fibroblast model
system. The different methods used to analyze receptor internal-
ization may also underlie the discrepancies between our data here
and the findings previously reported by Aarts [41]. Aarts’ group
used flow cytometry to examine internalization, whereas we used
more traditional methods employing radiolabeled ligand, temper-
ature shifting, and acid washing.
Our results also demonstrate that Tyr
729 and Tyr
764 of the G-
CSFR do not contribute to regulation of ligand-induced receptor
internalization. Aarts et. al. reported that deletion of the dileucine
motif including regions upstream or downstream of Tyr
744 or
Tyr
764 , respectively, resulted in a significant loss of receptor
internalization, but deletion of the region surrounding Tyr
729 did
not effect ligand-induced internalization of the receptor [41]. They
also reported that a deletion mutant containing the dileucine motif
but lacking amino acids surrounding Tyr
764 failed to properly
internalize, and suggested the YXXW motif localizing to that
region was important in modulating G-CSFR internalization In
this study, however, we found that mutation of Tyr
764 in this motif
had no effect, suggesting that other residues in the deletion mutant
described by Aarts et. al. are important [41]. Notably, in this same
region there are several serine residues and a lysine residue.
Recently, it has been reported that the lysine residue within the
dileucine motif of the CD3c was important for T-cell receptor
(TCR) internalization [42]. It was suggested that there may be a
requirement for a positively charged amino acid to facilitate
receptor internalization. It is possible that the lysine residue
upstream of the YXXW motif in the G-CSFR may be important in
the proper function of this motif.
As an alternative approach to investigate the mechanisms
responsible for the defective receptor internalization and degra-
dation characteristic of SCN/AML cells, we examined the effects
of insertion of a known receptor internalization motif into the
D716 G-CSFR. Attachment of the tyrosine-containing YTRF
internalization motif of the transferrin receptor 59 to the
premature stop codon of the D716 G-CSFR cDNA was shown
to restore receptor internalization back to normal but failed to
correct the defect in receptor degradation suggesting that the
internalized D716 receptor is not properly targeted to the
intracellular compartments responsible for degradation of the G-
CSFR. Our findings with the D716-YTRF G-CSFR suggest that
different processes and likely distinct subdomains in the G-CSFR
mediate receptor internalization and degradation. We have not
examined the potential role of other dileucine motifs in the G-
CSFR in mediating receptor internalizations. It is possible that
these other dileucine-containing sequences in the G-CSFR may
also contribute to G-CSFR internalization.
The use of distinct receptor subdomains by the G-CSFR to
regulate these processes would confer an increased capacity for a
single chain molecule to ‘‘fine tune’’ signals. Such a mechanism
might also be operative in other single chain members of the
cytokine receptor superfamily. Further studies of G-CSFR traffick-
ing patterns will help to elucidate the mechanisms responsible for
tight regulation of neutrophil numbers within a narrow range in
normal hematopoiesis which are disrupted in AML.
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